trial

Multi-target TMS for Schizophrenia Negative Symptoms

NCTId NCT07559084
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 64 (estimated)
Sponsored by Shanghai Mental Health Center
Primary completion 2027-12-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
64 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2026-05-01
Primary completion
2027-12-30
Eligibility
ALL · 16 Years · 45 Years

Interventions & indications

Drugs
repetitive Transcranial Magnetic Stimulation (rTMS)

Sponsors

Shanghai Mental Health CenterLead Sponsor

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
64
Phase
NA
Primary Completion Date
2027-12-30
Status
RECRUITING
relationships
The graph out of here
drug
repetitive Transcranial Magnetic Stimulation (rTMS)
drug
lead_sponsor
Shanghai Mental Health Center
company
indication
Schizophrenia
indication
SCHIZOPHRENIA 1 (Disorder)
indication